hims retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide for weight loss: Study

Summary: Retatrutide peptide is not approved in the UK and cannot be legally obtained outside a regulated clinical trial, as it has not received MHRA or EMA marketing authorisation

Side Effects and How They Are Managed Common side effects of Contrave include nausea, constipation, headache, dry mouth, or difficulty sleeping

Project results Nguyen and colleagues collected data on obesity drug prescriptions through electronic health records and pharmacy dispensing systems from January 2022 up to May 2025

This is more common than most men expect

What happens if I stop the medication

35 The recent phase 3 Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis (ESSENCE) trial showed that semaglutide 2.4 mg once weekly improved liver histology in patients with metabolic dysfunction-associated steatohepatitis with moderate or advanced liver fibrosis